MM
Mehrdad Mobasher
Hematology & Oncology
Credentials: · ·
History
- 2007–2010
- 2004–2007
University of California
Research
Venetoclax-Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
New England Journal of Medicine · 2018 · 784 citations
Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions
New England Journal of Medicine · 2019 · 715 citations
The Lancet Oncology · 2016 · 662 citations
5 papers
- AZ
3 papers
- IF
3 papers
- AP
2 papers
2 papers
- GS
2 papers
- JS
2 papers
2 papers
